Manokar Panchanatham

Prof. Dr. Manokar Panchanatham

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Pulmonary Circulation
Verified
Journal Article
Open access
PDF file
TMThoddi Ramamurthy Muralidharan
Thoddi Ramamurthy Muralidharan
SRSankaran Ramesh
Sankaran Ramesh
BKBalakrishnan Vinod Kumar
Balakrishnan Vinod Kumar
ARAditya V. Ruia
Aditya V. Ruia
MKMohan Kumar
Mohan Kumar
NSNagendra Boopathy Senguttuvan
Nagendra Boopathy Senguttuvan
Acute pulmonary thromboembolism is associated with high mortality, similar to that of myocardial infarction and stroke. We studied the clinical presentation and management of pulmonary thromboembolism in the Indian population. An analysis of 140 patients who presented with acute pulmonary thromboembolism at a large volume center in India from June 2015 through December 2018 was performed. The mean age of our study population was 50 years with 59% being male. Comorbidities including deep vein thrombosis, diabetes mellitus, hypertension, and chronic obstructive pulmonary disease were present in 52.9%, 40%, 35.7% and 7.14% of patients, respectively. Out of 140 patients, 40 (28.6%) patients had massive pulmonary thromboembolism, 36 (25.7%) sub‐massive pulmonary thromboembolism, and 64 (45.7%) had low‐risk pulmonary thromboembolism. Overall, in‐hospital mortality was 25.7%. Multivariate regression analysis found chronic kidney disease and pulmonary thromboembolism severity to be the only independent risk factors. Thrombolysis was performed in 62.5% of patients with a massive pulmonary thromboembolism and 63.9% of patients with a sub‐massive pulmonary thromboembolism. In the massive pulmonary thromboembolism group, patients receiving thrombolytic therapy had lower mortality compared with patients who did not receive therapy (p=0.022), whereas this difference was not observed in patients in the sub‐massive pulmonary thromboembolism group. We conclude that patients with acute pulmonary thromboembolism in India presented more than a decade earlier than our western counterparts, and it was associated with poor clinical outcomes. Thrombolysis was associated with significantly reduced in‐hospital mortality in patients with massive pulmonary thromboembolism.

11 April 2022 in JACC
Verified
Journal Article
Closed access
HSHarsimran Sachdeva Singh
Harsimran Sachdeva Singh
NSNagendra Boopathy Senguttuvan
Nagendra Boopathy Senguttuvan
RSRamesh Sankaran
Ramesh Sankaran
VBVinod Kumar Balakrishnan
Vinod Kumar Balakrishnan
SSS. Sadhanandham
S. Sadhanandham
TMThoddi Ramamurthy Muralidharan
Thoddi Ramamurthy Muralidharan

26 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SCSUNDAR CHIDAMBARAM
SUNDAR CHIDAMBARAM
Manokar PanchanathamManokar Panchanatham
Manokar Panchanatham
MVMahadevan Venkataramani
Mahadevan Venkataramani
MPMaheshbabu Panchanatham
Maheshbabu Panchanatham
JRJebaraj Rathinasamy
Jebaraj Rathinasamy
ASAshish H Shah
Ashish H Shah
Background/Objectives: Severe coronary calcification complicates percutaneous coronary intervention (PCI), and several calcium-modification technologies are available, but direct randomized comparisons are limited. We reviewed the comparative evidence on procedural success, complications and clinical outcomes. Methods: Comparative studies of coronary calcium-modification techniques during PCI that reported procedural, safety or clinical outcomes were eligible. PubMed and ClinicalTrials.gov were searched in May 2025 for records published from 1 April 2015 to 1 April 2025 (PROSPERO CRD420251077471; no external funding). We included 32 publications: eight randomized trials (10 publications) and 22 observational or descriptive studies. Evidence was organized in tiers and synthesized descriptively, without pooling, because definitions were heterogeneous and event rates were low. Risk of bias in randomized trials was assessed with RoB 2 where full texts were accessible. Results: Procedural success was generally high (usually 85–100%) and major complications were uncommon, but success definitions differed, and reported dissection (0% to over 80%) and slow-flow (0% to 31.6%) rates varied widely. Most comparative data were observational. In randomized comparisons, no device consistently outperformed another for procedural success, stent expansion or minimal stent area. Clinical outcome comparisons were limited by heterogeneous endpoints and low event rates. Risk of bias was rated from full texts for five out of the eight randomized trials, none at low risk overall; ratings for the others were provisional or not possible. Conclusions: The evidence is largely observational and of low certainty, and is insufficient to establish clinically meaningful differences among most technologies. Device selection should be lesion-specific and imaging-informed, and adequately powered head-to-head trials with standardized endpoints are needed.